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Extended spectrum beta-lactamases (ESBLs) confer resistance to clinically relevant antibiotics. Often, the resistance genes are
carried by conjugative plasmids which are responsible for dissemination. Five IncI1 plasmids carrying ESBLs from commensal
and clinical Escherichia coli isolates were completely sequenced and annotated along with a non-ESBL carrying IncI1 plasmid.
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Antibiotic resistance is a continuously growing concern fortreatment of bacterial infections in human and veterinary
medicine. Resistance genes are often carried by mobile genetic
elements such as plasmids through which resistance is spread
within an environment (1). Extended spectrum beta-lactamases
(ESBLs) are multidrug-resistant proteins which can hydrolyze a
variety of clinically relevant antibiotics such as penicillins and
cephalosporins. Frequently, ESBLs are carried by plasmids of the
incompatibility group I1 which are present inEscherichia coli from
diverse environments such as feces from animals in bio-industry
and wildlife, human clinical samples, and food stuffs intended for
human consumption (2–6). In general, IncI1 plasmids measure 90
to 120 kb and carry various antibiotic-resistant genes and plasmid
addiction systems (7, 8).
Five IncI1 plasmids were isolated from cefotaxime resistant
isolates and one from a cefotaxime susceptible isolate. The pres-
ence and types of ESBLs were determined by microarray and tar-
get specific PCR and sequencing (2), and plasmid sequence types
(ST) were determined by pMLST (9). Plasmids pESBL-12 (ST37)
and pESBL-117 (ST36), respectively, carry blaCTX-M-15 and
blaTEM-52, whereas pESBL-283 (ST7), pESBL-305 (ST3), and
pESBL-315 (incomplete ST) carry blaCTX-M-1 and pE17.16 (ST24)
carries no ESBLs. Plasmids pESBL-12 and pESBL-117 were pres-
ent in E. coli cultured from human urine samples, pESBL-283
from pig feces, and pESBL-305, pESBL-315, and pE17.16 from
chicken cecum content. These plasmids were selected for sequenc-
ing as they represent a broad selection of STs isolated from diverse
sources and they carry various ESBLs.
Next-generation whole-genome sequencing of the plasmids
was performed by shotgun XL pyrosequencing (454-Roche XL
sequencer). De novo assembly of the reads was performed using
Newbler v2.5.3. Scaffolds were built by custom scripts using syn-
teny of contigs determined by BLAT v34 (10) mapping on refer-
ence sequence R64 (7). These scaffolds (artificial chromosomes),
which also included any non-homologous contigs with reference
R64, were compared using customized Nucmer (MUMmer v3.07
[11]) scripts allowing sequence comparison and curation in
Artemis and ACT (12, 13). PCR and subsequent Sanger sequenc-
ing (ABI-Prism GA3130) were performed to close any gaps be-
tween the scaffolded contigs. Final annotation of the plasmids was
performed with the NCBI Prokaryotic annotation pipeline
(http://www.ncbi.nlm.nih.gov/genome/annotation_prok/) and
was manually curated.
The plasmids sequenced here range in size between 89,503 and
110,137 bp, the GC content of ranges between 49.5% and 51.4%
and between 101 and 129 coding sequences (CDSs) were pre-
dicted per plasmid. In addition to beta-lactamases, which are pres-
ent on all plasmids except additional plasmid pE17.16, various
resistance genes are present. Resistance to aminoglycosides, sul-
fonamide, and trimethoprim is carried by pESBL-283, pESBL-
305, and pESBL-315, whereas pESBL-12 carries resistance to ami-
noglycosides and pE17.16 carriess resistance to aminoglycosides
and sulfonamide.
Each of the plasmids carries the pndCA plasmid addiction sys-
tem in which translation of the toxin mRNA is prevented by an
unstable sRNA (7, 8, 14). In addition, pESBL-117 carries the vir-
ulence associated ribonuclease VapBC system (15) and pESBL-
283, pESBL-305, pESBL315, and pE17.16 carry the ribosome-
dependent mRNA cleavage system RelBE (16).
These nucleotide sequences confirm that there is high conser-
vation in the backbone of IncI1 plasmids.
Nucleotide sequence accession numbers. Genome sequences
have been submitted to GenBank under the accession numbers
listed in Table 1.
TABLE 1 Plasmid sequence accession numbers
Plasmid Accession number
pE17.16 CP008733
pESBL-117 CP008734
pESBL-12 CP008735
pESBL-283 CP008736
pESBL-305 CP008737
pESBL-315 CP008738
crossmark
Genome AnnouncementsJuly/August 2014 Volume 2 Issue 4 e00859-14 genomea.asm.org 1
ACKNOWLEDGMENT
This work was supported by the Ministry of Economic Affairs in The
Netherlands (160008-01).
REFERENCES
1. Carattoli A. 2013. Plasmids and the spread of resistance. Int. J. Med.
Microbiol. 303:298 –304. http://dx.doi.org/10.1016/j.ijmm.2013.02.001.
2. Veldman K, van Tulden P, Kant A, Testerink J, Mevius D. 2013.
Characteristics of cefotaxime-resistant Escherichia coli from wild birds in
the Netherlands. Appl. Environ. Microbiol. 79:7556 –7561. http://
dx.doi.org/10.1128/AEM.01880-13.
3. Veldman K, Kant A, Dierikx C, van Essen-Zandbergen A, Wit B,
Mevius D. 2014. Enterobacteriaceae resistant to third-generation cepha-
losporins and quinolones in fresh culinary herbs imported from Southeast
Asia. Int. J. Food Microbiol. 177:72–77. http://dx.doi.org/10.1016/ j.ij-
foodmicro.2014.02.014.
4. Dierikx CM, van der Goot JA, Smith HE, Kant A, Mevius DJ. 2013.
Presence of ESBL/AmpC-producing Escherichia coli in the broiler produc-
tion pyramid: a descriptive study. PLoS One 8:e79005. http://dx.doi.org/
10.1371/journal.pone.0079005.
5. Accogli M, Fortini D, Giufrè M, Graziani C, Dolejska M, Carattoli A,
Cerquetti M. 2013. IncI1 plasmids associated with the spread of CMY-2,
CTX-M-1 and SHV-12 in Escherichia coli of animal and human origin.
Clin. Microbiol. Infect. 19:E238 –E240. http://dx.doi.org/10.1111/1469
-0691.12128.
6. Leverstein-van Hall MA, Dierikx CM, Cohen Stuart J, Voets GM, van
den Munckhof MP, van Essen-Zandbergen A, Platteel T, Fluit AC, van
de Sande-Bruinsma N, Scharinga J, Bonten MJM, Mevius DJ, on behalf
of the National ESBL Surveillance Group. 2011. Dutch patients, retail
chicken meat and poultry share the same ESBL genes, plasmids and
strains. Clin. Microbiol. Infect. 17:873– 880. http://dx.doi.org/10.1111/
j.1469-0691.2011.03497.x.
7. Sampei G, Furuya N, Tachibana K, Saitou Y, Suzuki T, Mizobuchi K,
Komano T. 2010. Complete genome sequence of the incompatibility
group I1 plasmid R64. Plasmid 64:92–103. http://dx.doi.org/10.1016/
j.plasmid.2010.05.005.
8. Johnson TJ, Shepard SM, Rivet B, Danzeisen JL, Carattoli A. 2011.
Comparative genomics and phylogeny of the IncI1 plasmids: a common
plasmid type among porcine enterotoxigenic Escherichia coli. Plasmid 66:
144 –151. http://dx.doi.org/10.1016/j.plasmid.2011.07.003.
9. García-Fernández A, Chiaretto G, Bertini A, Villa L, Fortini D, Ricci A,
Carattoli A. 2008. Multilocus sequence typing of IncI1 plasmids carrying
extended-spectrum beta-lactamases in Escherichia coli and Salmonella of
human and animal origin. J. Antimicrob. Chemother. 61:1229 –1233.
http://dx.doi.org/10.1093/jac/dkn131.
10. Kent WJ. 2002. BLAT—the BLAST-like alignment tool. Genome Res.
12:656 – 664. http://dx.doi.org/10.1101/gr.229202.
11. Kurtz S, Phillippy A, Delcher AL, Smoot M, Shumway M, Antonescu C,
Salzberg SL. 2004. Versatile and open software for comparing large ge-
nomes. Genome Biol. 5:R12. http://dx.doi.org/10.1186/gb-2004-5-2-r12.
12. Rutherford K, Parkhill J, Crook J, Horsnell T, Rice P, Rajandream MA,
Barrell B. 2000. Artemis: sequence visualization and annotation. Bioin-
formatics 16:944 –945. http://dx.doi.org/10.1093/bioinformatics/
16.10.944.
13. Carver TJ, Rutherford KM, Berriman M, Rajandream MA, Barrell BG,
Parkhill J. 2005. ACT: the Artemis comparison Tool. Bioinformatics 21:
3422–3423. http://dx.doi.org/10.1093/bioinformatics/bti553.
14. Sakikawa T, Akimoto S, Ohnishi Y. 1989. The pnd gene in E. coli plasmid
R16: nucleotide sequence and gene expression leading to cell Mg2 re-
lease and stable RNA degradation. Biochim. Biophys. Acta 1007:158 –166.
http://dx.doi.org/10.1016/0167-4781(89)90034-1.
15. Arcus VL, McKenzie JL, Robson J, Cook GM. 2011. The PIN-domain
ribonucleases and the prokaryotic VapBC toxin-antitoxin array. Protein
Eng. Des. Sel. 24:33– 40. http://dx.doi.org/10.1093/protein/gzq081.
16. Christensen SK, Gerdes K. 2003. RelE toxins from bacteria and Archaea
cleave mRNAs on translating ribosomes, which are rescued by tmRNA.
Mol. Microbiol. 48:1389 –1400. http://dx.doi.org/10.1046/j.1365
-2958.2003.03512.x.
Brouwer et al.
Genome Announcements2 genomea.asm.org July/August 2014 Volume 2 Issue 4 e00859-14
